Internal Medicine, Gastroenterology · Southfield, MI
NPI
1578521217
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
22250 Providence Dr, 703
Southfield, MI, 48075
Phone (248) 569-1770
Groups this clinician bills Medicare through
Medicare paid, 2024
$132K
1,595 services
Medicare patients, 2024
678
Average age 74
Drug cost, 2024
$352K
1,689 prescriptions
Company payments, 2025
$4,305
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark Devore was code 88305 (surgical pathology examination), 379 times for 180 patients. In total Mark Devore billed 1,595 services in 38 codes, and Medicare paid $132K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 88305 Surgical Pathology Examination | Office | 379 | 180 | $25.93 | $9,828 |
| 99214 Office E&M - Established | Office | 237 | 207 | $90.94 | $22K |
| 99232 Hospital E&M - Subsequent | Facility | 161 | 98 | $60.75 | $9,781 |
| 45380 Lower GI Endoscopy - Other | Facility | 153 | 153 | $124.24 | $19K |
| 43239 Upper GI Endoscopy | Facility | 150 | 146 | $66.52 | $9,978 |
| 99223 Hospital E&M - Initial | Facility | 91 | 88 | $133.29 | $12K |
| 45385 Colonoscopy - Lesion Removal | Facility | 70 | 70 | $168.78 | $12K |
| 99204 Office E&M - New | Office | 63 | 63 | $111.54 | $7,027 |
| 99213 Office E&M - Established | Office | 49 | 45 | $64.77 | $3,174 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 41 | 41 | $172.32 | $7,065 |
| 99203 Office E&M - New | Office | 28 | 28 | $67.69 | $1,895 |
| 99222 Hospital E&M - Initial | Facility | 27 | 26 | $101.07 | $2,729 |
| 43248 Upper GI Endoscopy | Facility | 26 | 26 | $100.99 | $2,626 |
| 45388 Lower GI Endoscopy - Other | Facility | 16 | 16 | $222.97 | $3,568 |
| 45378 Lower GI Endoscopy - Other | Facility | 13 | 13 | $94.25 | $1,225 |
By year: 2022 $155K for 1,440 services; 2023 $166K for 1,743 services; 2024 $132K for 1,595 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 379 | 180 | $25.93 | $9,828 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark Devore prescribed most often to Medicare patients was Omeprazole, with 465 prescriptions and refills. In total Mark Devore wrote 1,689 Medicare prescriptions that cost $352K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 465 | 1,250 | 157 | $5,651 |
| Famotidine Generic | 155 | 445 | 54 | $4,772 |
| Pantoprazole Sodium Generic | 147 | 428 | 54 | $3,556 |
| Dicyclomine Hcl Generic | 77 | 133 | 38 | $1,412 |
| Cholestyramine Light Cholestyramine | 75 | 123 | 31 | $11K |
| Mesalamine Generic | 55 | 131 | 17 | $34K |
| Linzess Linaclotide | 53 | 103 | 20 | $56K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 37 | 37 | 21 | $815 |
| Sucralfate Generic | 34 | 86 | 16 | $1,578 |
| Ondansetron Hcl Generic | 32 | 40 | Under 11 | $302 |
| Lansoprazole Generic | 30 | 74 | Under 11 | $672 |
| Lactulose Generic | 29 | 56 | Under 11 | $2,739 |
| Prevalite Cholestyramine | 26 | 35 | Under 11 | $2,738 |
| Balsalazide Disodium Generic | 24 | 48 | Under 11 | $2,620 |
| Budesonide Ec Budesonide | 23 | 56 | Under 11 | $3,353 |
Brand drugs: 184 claims; generic drugs: 1,505 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark Devore $4,305 ($4,305 in general payments such as food, travel and fees) from 20 companies. The largest payer was Abbvie Inc. with $1,114.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 40 | $1,114 |
| Janssen Biotech, Inc. JNJ | 38 | $1,048 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 19 | $544 |
| Madrigal Pharmaceuticals MDGL | 5 | $222 |
| Pfizer Inc. PFE | 10 | $212 |
| QOL Medical, LLC | 5 | $210 |
| Lilly USA, LLC LLY | 9 | $167 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 7 | $146 |
| Aimmune Therapeutics, Inc. | 7 | $144 |
| Celltrion USA Inc. 068270.KS | 6 | $121 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.